CME Speakers
Asthma Case Studies
Stacey Denham, MSW, MPH
Stacey Denham, MSW, MPH
Public Health Manager
Stacey Denham, MSW, MPH, is a Public Health Manager at the Asthma and Allergy Foundation of America (AAFA), the nation’s oldest and leading asthma and allergy charity. She holds an MSW and MPH from Tulane University with a concentration in Maternal and Child Health. Stacey has worked in the asthma and allergy field for over 15 years with an emphasis in community health. She has worked both locally in her community of New Orleans and internationally with non-profit organizations. Stacy believes in the power, diversity, and resilience of each community and the leaders that reside in them to bring healthy behavior change to positive health outcomes. Currently, Stacey resides in New Orleans with her family, where they can be found bike riding, trying out new food spots, and going to festivals.
Anju Peters, MD, MS
Anju Peters, MD, MS
Professor of Medicine
Anju Peters, MD, MS, is a Professor in the Department of Medicine at Northwestern. Moreover, she is the Director of Clinical Research in the Division of Allergy-Immunology and the Medical Director of the Northwestern Medicine Clinical Research Unit. Furthermore, Dr. Peters is the Director of the Center for Clinical Research at the Northwestern University Clinical and Translational Sciences Institute. Her research focuses on the field of chronic rhinosinusitis and its associated comorbidities including allergic rhinitis, asthma and immunodeficiencies. Dr. Peters has published extensively in these areas and is currently involved in translational research and clinical trials in asthma and chronic rhinosinusitis. Currently, she practices as an allergist in the Division of Allergy-Immunology.
Theresa Guilbert, MD, MS
Theresa Guilbert, MD, MS
Professor
Theresa Guilbert, MD, MS, is a Professor at the University of Cincinnati and the Director of the Asthma Center at Cincinnati Children’s Hospital & Medical Center. Dr. Guilbert’s clinical research focuses on identifying the roles of risk factors, exposures, and environment interactions that lead to early childhood wheezing and severe asthma as well as treatment and intervention strategies to manage asthma. Her clinical research has utilized stakeholder input to develop, implement, and test technology-based interventions for children with asthma, and she has developed a telehealth clinic which serves several urban core school-based health centers. Dr. Guilbert is currently the site PI for several multi-center asthma pediatric trials.
Nasal Polyps Management
Kathleen Buchheit, MD
Kathleen Buchheit, MD
Assistant Professor of Medicine
Katie Buchheit, MD, is the assistant director of the AERD Center at the Brigham and Women’s Hospital (BWH) in Boston, Massachusetts. Her research focuses on understanding aspirin-exacerbated respiratory disease (AERD) and nasal polyposis. She is dedicated to investigating the causative mechanisms and exploring new treatments for these diseases. Dr. Buchheit is principal investigator of an NIH-funded study investigating the role of B cells and plasma cells in the pathogenesis of AERD and nasal polyps, as well as the mechanistic factors associated with nasal polyp recurrence. Clinically, she primarily focuses on the treatment of patients with chronic rhinosinusitis and AERD. During her allergy/immunology fellowship at BWH, she focused on the pathogenesis of nasal polyposis and AERD..jpg)
Stella Lee, MD
Stella Lee, MD
Director of the Brigham Sinus Center
Stella Lee, MD is a fellowship-trained rhinologist and chief of rhinology at Brigham and Women’s Hospital (BWH)/Harvard Medical School in Boston, Massachusetts. She is a clinician scientist developing novel management strategies for the care of patients with inflammatory upper airway disease and is a leader in developing therapeutics for airway inflammation. Before joining BWH, Dr. Lee was the division chief for sino-nasal disorders and allergy in the Department of Otolaryngology at the University of Pittsburgh Medical Center for ten years. Her research interests include defining inflammatory endotypes of chronic rhinosinusitis, the impact of environmental pollution on airway inflammation, and the development of basic to translational approaches to solve chronic inflammation.Noam Cohen, MD, PhD
Noam Cohen, MD, PhD
Professor of Otorhinolaryngology – Head and Neck Surgery, Director of Rhinology Research
Noam Cohen, MD, PhD is the Ralph Butler endowed professor of otorhinolaryngology – head and neck surgery and director of rhinology research at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. He is an adjunct member of the Monell Chemical Senses Center and a staff surgeon at the Philadelphia VA Medical Center. His research interests include host-microbe interactions in the upper airway, focusing on sinonasal innate defenses (airway taste receptors and mucociliary clearance), microbial biofilms, solitary chemosensory cells, and development of novel sinonasal topical antimicrobial therapies. He has authored more than 200 publications, given multiple presentations around the world, and has been principal investigator on NIH and VA grants, as well as industry-sponsored studies.
.jpg)
Nasal Polyps Case Studies
Stacey Denham, MSW, MPH
Stacey Denham, MSW, MPH
Public Health Manager
Stacey Denham, MSW, MPH, is a Public Health Manager at the Asthma and Allergy Foundation of America (AAFA), the nation’s oldest and leading asthma and allergy charity. She holds an MSW and MPH from Tulane University with a concentration in Maternal and Child Health. Stacey has worked in the asthma and allergy field for over 15 years with an emphasis in community health. She has worked both locally in her community of New Orleans and internationally with non-profit organizations. Stacy believes in the power, diversity, and resilience of each community and the leaders that reside in them to bring healthy behavior change to positive health outcomes. Currently, Stacey resides in New Orleans with her family, where they can be found bike riding, trying out new food spots, and going to festivals.Stella Lee, MD
Stella Lee, MD
Director of the Brigham Sinus Center
Stella Lee, MD is a fellowship-trained rhinologist and chief of rhinology at Brigham and Women’s Hospital (BWH)/Harvard Medical School in Boston, Massachusetts. She is a clinician scientist developing novel management strategies for the care of patients with inflammatory upper airway disease and is a leader in developing therapeutics for airway inflammation. Before joining BWH, Dr. Lee was the division chief for sino-nasal disorders and allergy in the Department of Otolaryngology at the University of Pittsburgh Medical Center for ten years. Her research interests include defining inflammatory endotypes of chronic rhinosinusitis, the impact of environmental pollution on airway inflammation, and the development of basic to translational approaches to solve chronic inflammation.
Nasal Polyps Expert Interview
Eugenio De Corso, MD, PhD
Eugenio De Corso, MD, PhD
Ear, Nose, and Throat Specialist
Eugenio De Corso, MD, PhD is an ear, nose, and throat specialist at the Institute of Otorhinolaryngology, A. Gemelli University Hospital Foundation, Catholic University of the Sacred Heart in Rome, Italy. His principal areas of clinical expertise are nasal polyps, chronic rhinosinusitis, allergic and nonallergic rhinitis, sinusitis, and otitis media. His research interests include endoscopic treatment, laryngectomy, brachytherapy, otosclerosis surgery, type 2 inflammation in nonallergic rhinitis, and the management of patients with chronic rhinosinusitis with nasal polyps (CRSwNP). He has overseen clinical studies of patients undergoing new therapies, such as biologics for severe uncontrolled CRSwNP and the efficacy of biologics on refractory eosinophilic otitis media associated with CRSwNP. He has authored or co-authored more than 100 publications and has reviewed several international journals.
Marco Caminati, MD
Marco Caminati, MD
Allergy and Clinical Immunology Specialist
Marco Caminati, MD is an allergy and clinical immunology specialist, as well as an assistant professor in allergy, clinical immunology, and severe asthma at the University of Verona Asthma Center and Allergy Unit at Verona University Hospital in Verona, Italy. Most of his clinical and scientific activity focuses on asthma, severe asthma, and associated comorbidities, including chronic rhinosinusitis with nasal polyps (CRSwNP), as well as biologics and immunotherapy. His research interests include rare autoimmune disorders with hypereosinophilic syndrome (HES), eosinophilic granulomatosis with polyangiitis (EGPA), and eosinophilic esophagitis (EoE), with a special focus on new targeted therapies. He co-chaired the Junior Members Steering Group of the World Allergy Organization (WAO) and was involved in the European Academy of Allergy and Clinical Immunology (EAACI) Junior Member Assembly.
Seeking Control for Moderate‐to‐Severe Asthma
Michael Wechsler, MD, MMSc
Michael Wechsler, MD, MMSc
Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine
Michael Wechsler, MD, MMSc, is a Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at National Jewish Health (NJH), Director of the NJH/Cohen Family Asthma Institute, and Associate Vice President for Innovation and Industry Relations at NJH. In addition to clinical work in pulmonary & critical care medicine, Dr. Wechsler’s research focuses on clinical and translational asthma with emphasis on clinical trials in asthma, novel asthma therapies, bronchial thermoplasty, asthma pharmacogenomics, and management of eosinophilic granulomatosis with polyangiitis (i.e. Churg-Strauss Syndrome, CSS). He has led studies focusing on novel biologic agents for asthma and related diseases, including benralizumab, dupilumab, mepolizumab, reslizumab, and tezepelumab.Anju Peters, MD, MS
Anju Peters, MD, MS
Professor of Medicine
Anju Peters, MD, MS, is a Professor in the Department of Medicine at Northwestern. Moreover, she is the Director of Clinical Research in the Division of Allergy-Immunology and the Medical Director of the Northwestern Medicine Clinical Research Unit. Furthermore, Dr. Peters is the Director of the Center for Clinical Research at the Northwestern University Clinical and Translational Sciences Institute. Her research focuses on the field of chronic rhinosinusitis and its associated comorbidities including allergic rhinitis, asthma and immunodeficiencies. Dr. Peters has published extensively in these areas and is currently involved in translational research and clinical trials in asthma and chronic rhinosinusitis. Currently, she practices as an allergist in the Division of Allergy-Immunology.
All Speakers
Stacey Denham, MSW, MPH
Stacey Denham, MSW, MPH
Public Health Manager
Stacey Denham, MSW, MPH, is a Public Health Manager at the Asthma and Allergy Foundation of America (AAFA), the nation’s oldest and leading asthma and allergy charity. She holds an MSW and MPH from Tulane University with a concentration in Maternal and Child Health. Stacey has worked in the asthma and allergy field for over 15 years with an emphasis in community health. She has worked both locally in her community of New Orleans and internationally with non-profit organizations. Stacy believes in the power, diversity, and resilience of each community and the leaders that reside in them to bring healthy behavior change to positive health outcomes. Currently, Stacey resides in New Orleans with her family, where they can be found bike riding, trying out new food spots, and going to festivals.Anju Peters, MD, MS
Anju Peters, MD, MS
Professor of Medicine
Anju Peters, MD, MS, is a Professor in the Department of Medicine at Northwestern. Moreover, she is the Director of Clinical Research in the Division of Allergy-Immunology and the Medical Director of the Northwestern Medicine Clinical Research Unit. Furthermore, Dr. Peters is the Director of the Center for Clinical Research at the Northwestern University Clinical and Translational Sciences Institute. Her research focuses on the field of chronic rhinosinusitis and its associated comorbidities including allergic rhinitis, asthma and immunodeficiencies. Dr. Peters has published extensively in these areas and is currently involved in translational research and clinical trials in asthma and chronic rhinosinusitis. Currently, she practices as an allergist in the Division of Allergy-Immunology.Theresa Guilbert, MD, MS
Theresa Guilbert, MD, MS
Professor
Theresa Guilbert, MD, MS, is a Professor at the University of Cincinnati and the Director of the Asthma Center at Cincinnati Children’s Hospital & Medical Center. Dr. Guilbert’s clinical research focuses on identifying the roles of risk factors, exposures, and environment interactions that lead to early childhood wheezing and severe asthma as well as treatment and intervention strategies to manage asthma. Her clinical research has utilized stakeholder input to develop, implement, and test technology-based interventions for children with asthma, and she has developed a telehealth clinic which serves several urban core school-based health centers. Dr. Guilbert is currently the site PI for several multi-center asthma pediatric trials.Kathleen Buchheit, MD
Kathleen Buchheit, MD
Assistant Professor of Medicine
Katie Buchheit, MD, is the assistant director of the AERD Center at the Brigham and Women’s Hospital (BWH) in Boston, Massachusetts. Her research focuses on understanding aspirin-exacerbated respiratory disease (AERD) and nasal polyposis. She is dedicated to investigating the causative mechanisms and exploring new treatments for these diseases. Dr. Buchheit is principal investigator of an NIH-funded study investigating the role of B cells and plasma cells in the pathogenesis of AERD and nasal polyps, as well as the mechanistic factors associated with nasal polyp recurrence. Clinically, she primarily focuses on the treatment of patients with chronic rhinosinusitis and AERD. During her allergy/immunology fellowship at BWH, she focused on the pathogenesis of nasal polyposis and AERD.Stella Lee, MD
Stella Lee, MD
Director of the Brigham Sinus Center
Stella Lee, MD is a fellowship-trained rhinologist and chief of rhinology at Brigham and Women’s Hospital (BWH)/Harvard Medical School in Boston, Massachusetts. She is a clinician scientist developing novel management strategies for the care of patients with inflammatory upper airway disease and is a leader in developing therapeutics for airway inflammation. Before joining BWH, Dr. Lee was the division chief for sino-nasal disorders and allergy in the Department of Otolaryngology at the University of Pittsburgh Medical Center for ten years. Her research interests include defining inflammatory endotypes of chronic rhinosinusitis, the impact of environmental pollution on airway inflammation, and the development of basic to translational approaches to solve chronic inflammation.Noam Cohen, MD, PhD
Noam Cohen, MD, PhD
Professor of Otorhinolaryngology – Head and Neck Surgery, Director of Rhinology Research
Noam Cohen, MD, PhD is the Ralph Butler endowed professor of otorhinolaryngology – head and neck surgery and director of rhinology research at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. He is an adjunct member of the Monell Chemical Senses Center and a staff surgeon at the Philadelphia VA Medical Center. His research interests include host-microbe interactions in the upper airway, focusing on sinonasal innate defenses (airway taste receptors and mucociliary clearance), microbial biofilms, solitary chemosensory cells, and development of novel sinonasal topical antimicrobial therapies. He has authored more than 200 publications, given multiple presentations around the world, and has been principal investigator on NIH and VA grants, as well as industry-sponsored studies.Eugenio De Corso, MD, PhD
Eugenio De Corso, MD, PhD
Ear, Nose, and Throat Specialist
Eugenio De Corso, MD, PhD is an ear, nose, and throat specialist at the Institute of Otorhinolaryngology, A. Gemelli University Hospital Foundation, Catholic University of the Sacred Heart in Rome, Italy. His principal areas of clinical expertise are nasal polyps, chronic rhinosinusitis, allergic and nonallergic rhinitis, sinusitis, and otitis media. His research interests include endoscopic treatment, laryngectomy, brachytherapy, otosclerosis surgery, type 2 inflammation in nonallergic rhinitis, and the management of patients with chronic rhinosinusitis with nasal polyps (CRSwNP). He has overseen clinical studies of patients undergoing new therapies, such as biologics for severe uncontrolled CRSwNP and the efficacy of biologics on refractory eosinophilic otitis media associated with CRSwNP. He has authored or co-authored more than 100 publications and has reviewed several international journals.Marco Caminati, MD
Marco Caminati, MD
Allergy and Clinical Immunology Specialist
Marco Caminati, MD is an allergy and clinical immunology specialist, as well as an assistant professor in allergy, clinical immunology, and severe asthma at the University of Verona Asthma Center and Allergy Unit at Verona University Hospital in Verona, Italy. Most of his clinical and scientific activity focuses on asthma, severe asthma, and associated comorbidities, including chronic rhinosinusitis with nasal polyps (CRSwNP), as well as biologics and immunotherapy. His research interests include rare autoimmune disorders with hypereosinophilic syndrome (HES), eosinophilic granulomatosis with polyangiitis (EGPA), and eosinophilic esophagitis (EoE), with a special focus on new targeted therapies. He co-chaired the Junior Members Steering Group of the World Allergy Organization (WAO) and was involved in the European Academy of Allergy and Clinical Immunology (EAACI) Junior Member Assembly.Michael Wechsler, MD, MMSc
Michael Wechsler, MD, MMSc
Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine
Michael Wechsler, MD, MMSc, is a Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at National Jewish Health (NJH), Director of the NJH/Cohen Family Asthma Institute, and Associate Vice President for Innovation and Industry Relations at NJH. In addition to clinical work in pulmonary & critical care medicine, Dr. Wechsler’s research focuses on clinical and translational asthma with emphasis on clinical trials in asthma, novel asthma therapies, bronchial thermoplasty, asthma pharmacogenomics, and management of eosinophilic granulomatosis with polyangiitis (i.e. Churg-Strauss Syndrome, CSS). He has led studies focusing on novel biologic agents for asthma and related diseases, including benralizumab, dupilumab, mepolizumab, reslizumab, and tezepelumab.